FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:684-687 March 5, 1998 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Wiklund, R. A. PubMed Citation

To the Editor: In an otherwise excellent and long-overdue review of anesthesiology, Wiklund and Rosenbaum (Oct. 16 and 23 issues)¹ have included several errors. Their discussion of halothane, in the section on inhalational anesthetics in part 1, states, "Hepatotoxicity has not been reported in children." In fact, halothane hepatitis has been reported in children, although it is generally agreed that the incidence in children is lower than that in adults.² The authors also state, "Desflurane is highly fluorinated, nearly as insoluble as nitrous oxide, and as potent as isoflurane." One of the minor disadvantages of desflurane is that it is . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Davis, M. M., Patel, M. S., Gebremariam, A. (2004). Decline in Varicella-Related Hospitalizations and Expenditures for Children and Adults After Introduction of Varicella Vaccine in the United States. Pediatrics 114: 786-792 [Abstract] [Full Text]  
• Wack, R. P. (1998). More on Varicella Immunization. NEJM 338: 1927-1927 [Full Text]